Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Zika Virus Infection, January 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 58 articles: HTML format

Single Articles

1. OOI EE
   Zika immune imprint risks dengue.
   Nat Immunol. 2026 Jan 2. doi: 10.1038/s41590-025-02365.
   PubMed    
   
   
   

2. CARDONA-OSPINA JA, Roy V, Marcano-Jimenez DE, Bos S, et al
   IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans.
   Nat Immunol. 2026 Jan 2. doi: 10.1038/s41590-025-02363.
   PubMed    
   Abstract available
   
   

3. DHAR R, Singh S, Sahoo OS, Chandra N, et al
   The placental battlefield: viral strategies and immune countermeasures.
   Front Immunol. 2025;16:1667601.
   PubMed    
   Abstract available
   
   

4. PIMENTA JC, Pereira JAB, Teixeira DC, da Silva Santos FR, et al
   Methods for Evaluating Neurotropic Viral Infections: Exploring Zika and Coronavirus Diseases.
   Methods Mol Biol. 2026;2993:215-264.
   PubMed    
   Abstract available
   
   

5. BATISTA VL, Martins JR, Teixeira DC, Pereira JAB, et al
   Platforms to Evaluate Flavivirus-Induced Immunoinflammatory Responses and Their Pathogenesis.
   Methods Mol Biol. 2026;2993:195-213.
   PubMed    
   Abstract available
   
   

6. LIMA LR, Mustafa YM, Fonseca PLC, Coelho SVA, et al
   Distinct ZIKV strain signatures and type I IFN modulation reveal a protective role of brain endothelial interferon signaling in vitro and in vivo.
   Front Cell Infect Microbiol. 2025;15:1726007.
   PubMed    
   Abstract available
   
   

7. LIMA LR, Mustafa YM, Fonseca PLC, Coelho SVA, et al
   Correction: Distinct ZIKV strain signatures and type I IFN modulation reveal a protective role of brain endothelial interferon signaling in vitro and in vivo.
   Front Cell Infect Microbiol. 2025;15:1762181.
   PubMed    
   Abstract available
   
   

8. SHENOY DR, Ananthanarayanan R, Niyas VKM, R V, et al
   Zika Virus Disease in Pregnancy: A Case Series from the Kerala Outbreak.
   J Obstet Gynaecol India. 2025;75:517-520.
   PubMed    
   Abstract available
   
   

9. OLIVEIRA HFV, Rego FRQ, Cavalcanti BS, Bacellar IR, et al
   [Reply to the Letter to the Editor Regarding "Description of Hip Deformities in 5-Year-Old Patients with Congenital Zika Virus Syndrome: A Cross-Sectional Study"].
   Rev Bras Ortop (Sao Paulo). 2025;60:s00451814119.
   PubMed    
   
   
   

10. OLIVEIRA HFV, Rego FRQ, Cavalcanti BS, Bacellar IR, et al
    Reply to the Letter to the Editor Regarding "Description of Hip Deformities in 5-Year-Old Patients with Congenital Zika Virus Syndrome: A Cross-Sectional Study".
    Rev Bras Ortop (Sao Paulo). 2025;60:s00451814118.
    PubMed    
    
    
    

11. KLEEBAYOON A, Wiwanitkit V
    Description of Hip Deformities in 5-Year-Old Patients with Congenital Zika Virus Syndrome.
    Rev Bras Ortop (Sao Paulo). 2025;60:s00451814120.
    PubMed    
    
    
    

12. KLEEBAYOON A, Wiwanitkit V
    [Description of Hip Deformities in 5-Year-Old Patients with Congenital Zika Virus Syndrome].
    Rev Bras Ortop (Sao Paulo). 2025;60:s00451814121.
    PubMed    
    
    
    

13. CALDERON-PELAEZ MA, Velandia-Romero ML, Castellanos JE
    In vivo and in vitro susceptibility and inflammatory response of postnatal mouse cortical neurons and glial cells to zika virus infection.
    PLoS One. 2025;20:e0339900.
    PubMed    
    Abstract available
    
    

14. MENEZES A, Walter-Nuno AB, Costa-Bartuli E, Moreira D, et al
    A diet-induced obese and diabetic host phenotype reduces mosquito ZIKV infections and remodels gut metabolism.
    Front Immunol. 2025;16:1704301.
    PubMed    
    Abstract available
    
    

15. LIU Y, Zhang J, Zhu J, Ni H, et al
    Generation of a Human-Mouse Chimeric Anti-Japanese Encephalitis Virus and Zika Virus Monoclonal Antibody Using CDR Grafting.
    Microorganisms. 2025;13:2868.
    PubMed    
    Abstract available
    
    

16. BALAKRISHNAN B, Arul SS, Ravindran A, Venkataraman S, et al
    Competitive Viral Interference Controls Arbovirus Co-Transmission in Aedes aegypti.
    Sci Rep. 2025;15:45679.
    PubMed    
    Abstract available
    
    

17. LEE YJ, Kang N, Heo JH, Kim EA, et al
    Antiviral Activity of Ethyl Gallate Against Zika Virus: In Vitro and In Silico Studies.
    Int J Mol Sci. 2025;26:12062.
    PubMed    
    Abstract available
    
    

18. MIRANDA-FILHO DB, Ximenes RAA, Ramos Montarroyos U, Rosa Abtibol-Bernardino M, et al
    Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium.
    PLOS Glob Public Health. 2025;5:e0005425.
    PubMed    
    Abstract available
    
    

19. TAMAYO-MOLINA YS, Garcia-Marin Y, Urcuqui-Inchima S
    2-Deoxy-D-glucose attenuates lipopolysaccharide-induced inflammation and restricts Zika, Chikungunya, and Mayaro virus replication in monocyte-derived macrophages.
    Antiviral Res. 2025;246:106338.
    PubMed    
    Abstract available
    
    

20. VIDAL HDA, Mesquita NCMR, Bernardes ACB, Mourao PS, et al
    Fragment-based discovery and optimization of Zika virus NS3 helicase ligands as antiviral hit candidates.
    Eur J Med Chem. 2025;304:118521.
    PubMed    
    Abstract available
    
    

21. SANOU AM, Nikiema AS, Sausy A, Diendere J, et al
    Serologic Evidence of Circulation of Six Arboviruses (Dengue Virus, Chikungunya Virus, Zika Virus, Rift Valley Virus, Yellow Fever Virus, Crimean-Congo Hemorrhagic Fever Virus) in Four Regions of Burkina Faso, West Africa.
    Trop Med Infect Dis. 2025;10:345.
    PubMed    
    Abstract available
    
    

22. SHARIFF Y, Malik MA, Abbas M
    Congenital Zika Syndrome Presenting With Late-Onset Seizures: A New Phenotypic Variant.
    Pediatr Infect Dis J. 2025 Dec 24. doi: 10.1097/INF.0000000000005126.
    PubMed    
    
    
    

23. ABISI HK, Ghezzi S, Pagani I, Vicenzi E, et al
    In vitro Control of RNA Virus Infections by M1-Polarized Human Monocyte-Derived Macrophages.
    New Microbiol. 2025;48:287-292.
    PubMed    
    Abstract available
    
    

24. WANG Y, Galkin A, Shang X, Marin A, et al
    Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk.
    Nat Commun. 2025;16:11558.
    PubMed    
    Abstract available
    
    

25. SMITH AJ, Rahat MA, Scaramozza LJ, Eyles SJ, et al
    Inhibition of Zika Virus Protease by Modulating NS2B-NS3 Interactions.
    Biochemistry. 2025 Dec 22. doi: 10.1021/acs.biochem.5c00644.
    PubMed    
    Abstract available
    
    

26. ADIA NAB, Shah PS
    Image-based morphological profiling of autophagy phenotypes in Zika virus infected cells.
    bioRxiv [Preprint]. 2025 Dec 11:2025.12.09.693313.
    PubMed    
    Abstract available
    
    

27. GUIMARAES-ANDRADE IP, Barboza RS, da Silva MOL, da Conceicao RA, et al
    Bioactive Flavanone Glycoside Isolated from Leaves of Faramea Species Presents Antiviral and Protective Activity against Zika and Mayaro Virus Infection.
    ACS Omega. 2025;10:60196-60204.
    PubMed    
    Abstract available
    
    

28. ROBIN P, Gerber-Lemaire S
    Assessment of Hairpin-Functionalization of Gold Nanoparticles toward a Facile Detection of Zika Virus and Lineage Identification.
    ACS Omega. 2025;10:60900-60911.
    PubMed    
    Abstract available
    
    

29. ZHENG X, Yan X, Xu X, Heng L, et al
    Preliminary survey of dengue, Zika and chikungunya viruses by nucleic acid test in blood donors in Shenzhen, China.
    Front Public Health. 2025;13:1672814.
    PubMed    
    Abstract available
    
    

30. RICHARDSON RB, Kikawa C, Garg A, Bednarski E, et al
    Coevolutionary constraints of Zika virus nonstructural protein 5 replication and interferon antagonism activities.
    bioRxiv [Preprint]. 2025 Dec 23:2025.12.23.696258.
    PubMed    
    Abstract available
    
    

31. FALCAO DE OLIVEIRA E, Carvalho AT, Venancio FA, Quiliao ME, et al
    Zika virus infection in early pregnancy increases the likelihood of persistent neutralizing antibodies.
    PLoS Negl Trop Dis. 2026;20:e0013906.
    PubMed    
    Abstract available
    
    

32. KIM J, Lee W, Kim DY, Ku KB, et al
    Brain-infiltrating CD8 T cells retain functional activity to protect against acute Zika virus infection.
    Sci Rep. 2026 Jan 5. doi: 10.1038/s41598-026-35079.
    PubMed    
    Abstract available
    
    

33. RODRIGUES T, Beltrao GS, Girardi H, Pinto AR, et al
    Viral reprogramming of glial metabolism as a driver of neuroinflammation.
    Front Immunol. 2025;16:1686774.
    PubMed    
    Abstract available
    
    

34. SUN X, Jiang H, Yu W, Wang N, et al
    Multivalent display of Envelope protein domain III with Mi3 nanoparticles induces protective immunity against lethal Zika virus infection in mice.
    Virol Sin. 2026 Jan 2:S1995-820X(25)00192-0. doi: 10.1016/j.virs.2025.
    PubMed    
    Abstract available
    
    

35. BRAZ-DE-MELO HA, Lago FG, Correa R, Santos IO, et al
    Zika Virus Reprograms Microglial Mitochondrial Metabolism to Support Immune Activation and Viral Replication: Omega-3 DHA Counteracts Neuroinflammation and Viral Persistence.
    Mol Neurobiol. 2026;63:341.
    PubMed    
    Abstract available
    
    

36. IZABAYO P, Hakizimana JC, Uwineza A, Alagbonsi AI, et al
    Environmental factors associated with microcephaly in Africa: A systematic review.
    Neurotoxicol Teratol. 2026;113:107577.
    PubMed    
    Abstract available
    
    

37. DE OLIVEIRA JHP, Arruda IES, de Sena Junior MR, de Oliveira FHC, et al
    Beyond DALY: public funding of health innovation in Brazil as a political strategy for equity in the Global South.
    BMC Public Health. 2025;26:56.
    PubMed    
    Abstract available
    
    

38. PLENTZ I, Pazzin D, Previato T, Wagner F, et al
    Influence of IgG+ serum on Zika virus infection response in a model of neural precursor cells.
    Biochem Biophys Rep. 2025;44:102260.
    PubMed    
    Abstract available
    
    

39. MOURA LG, Ianni AMZ
    [The technoscientific production of zika virus and zika disease: risks and insecurity in the health field].
    Hist Cienc Saude Manguinhos. 2026;32:e2025058.
    PubMed    
    Abstract available
    
    

40. GRECO LF, da Silva RGL, de Campos AS, da Costa JP, et al
    'Well... we keep adapting our labs': Interconnected factors shaping vaccine R&D and production capacity in Brazil.
    Glob Public Health. 2026;21:2614156.
    PubMed    
    Abstract available
    
    

41. PEREIRA RS, Campana PRV, Costa VV, Maltarollo VG, et al
    Bioactivity-Guided Isolation of beta-Sitosterol From Terminalia glabrescens as a Potent Anti-Zika Virus Agent.
    Chem Biodivers. 2026;23:e02860.
    PubMed    
    Abstract available
    
    

42. AZEVEDO LMS, Rios DL, Diniz LNA, de Oliveira SN, et al
    Effect of antibody-dependent enhancement on the development of the offspring of mice infected by Zika virus: Analysis of the brain transcriptome.
    Microb Pathog. 2026;212:108292.
    PubMed    
    Abstract available
    
    

43. SCIRE EM, Huang AL, Boccia T, Kycia I, et al
    Transamniotic Fetal mRNA Vaccination: Active Immunization Against Zika Virus in a Rodent Model.
    J Pediatr Surg. 2026 Jan 9:162922. doi: 10.1016/j.jpedsurg.2026.162922.
    PubMed    
    Abstract available
    
    

44. CHEN XZ, Gong YX, Guo HX, He JX, et al
    Study on the spatiotemporal regulation of interferon-stimulated genes during Zika virus infection.
    Front Immunol. 2026;16:1702266.
    PubMed    
    Abstract available
    
    

45. CAMPBELL H, Morris TP, Gustafson P
    A Fully-Integrated Bayesian Approach for the Imputation and Analysis of Derived Outcome Variables With Missingness.
    Stat Med. 2026;45.
    PubMed    
    Abstract available
    
    

46. BRITO ASS, Meira CAC, Moreira KMA, Santino TA, et al
    Sensorial function in children with congenital Zika syndrome: what is the relationship with motor function?
    Rev Paul Pediatr. 2026;44:e2025112.
    PubMed    
    Abstract available
    
    

47. MARQUINE S, Mura M, de Laval F, Grard G, et al
    Longitudinal Monitoring of Systemic Cytokines After Mild Zika Virus Infection Revealed an Association Between Th17 Polarization and Clinical and Serological Outcomes.
    J Med Virol. 2026;98:e70813.
    PubMed    
    Abstract available
    
    

48. HUANG YL, Chen HM, He HW, Lu ZH, et al
    A Point-of-Care Platform for Simultaneous Triplex PCR Detection of Chikungunya, Dengue, and Zika Virus Infections.
    J Vis Exp. 2025;.
    PubMed    
    Abstract available
    
    

49. MARTIN H, Martin C, Guimbaud L, Duchanois D, et al
    Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface.
    J Vis Exp. 2025;.
    PubMed    
    Abstract available
    
    

50. SANTOS R, Mekonnen ZA, Yeow AEL, Whelan DM, et al
    Multi-antigen DNA vaccine targeting non-structural proteins confers robust T Cell-mediated protection against Zika virus.
    NPJ Vaccines. 2026 Jan 17. doi: 10.1038/s41541-025-01356.
    PubMed    
    Abstract available
    
    

51. CHOU TW, McCourt M, Marmut E, Karuppusamy V, et al
    Inapparent maternal ZIKV infection impacts fetal brain development and postnatal behavior.
    PLoS Pathog. 2026;22:e1013850.
    PubMed    
    Abstract available
    
    

52. HUAI Y, Wang X, Yan J, Li S, et al
    Emerging viroporins, RBP dynamics, and skeletal remodeling: Targeting liquid-liquid phase separation for dual antiviral and bone-protective therapies.
    Mol Aspects Med. 2026;107:101445.
    PubMed    
    Abstract available
    
    

53. ZHANG S, Chen D, Zhang K, Liu M, et al
    ZIKV infection causes placental inflammation through activating PANoptosis.
    J Virol. 2025;99:e0175925.
    PubMed    
    Abstract available
    
    

54. FERDOUS J, Nasif MAO, Cowman G, Muntasir I, et al
    Zika Virus Outbreak - Bangladesh, September-December 2024.
    MMWR Morb Mortal Wkly Rep. 2026;75:1-6.
    PubMed    
    Abstract available
    
    

55. BACCIN F, Montenegro MA
    Congenital Zika Syndrome.
    N Engl J Med. 2026;394:e2.
    PubMed    
    
    
    

56. SHU B, Ng TS, Lim XN, Zhang S, et al
    An ultrapotent human antibody neutralizes all maturation states of Zika virus.
    Proc Natl Acad Sci U S A. 2025;122:e2502522122.
    PubMed    
    Abstract available
    
    

57. ROBA A, Kiiru J, Kirui E, Langat P, et al
    Molecular diagnosis of arboviruses (dengue, Chikungunya, yellow fever, Rift Valley fever, Mayaro, West Nile, and Zika viruses) in non-malaria acute febrile illnesses in Kenya's Garissa County, July 2023, and Mombasa County, July 2024.
    BMC Infect Dis. 2026;26:27.
    PubMed    
    
    
    

58. DEL VALLE-MENDOZA J, Watson H, Tarazona-Castro Y, Silva-Caso W, et al
    Temporal cytokine profiling of acute dengue, Zika, Chikungunya, and Mayaro virus infections in Northern Peru.
    BMC Infect Dis. 2026 Jan 17. doi: 10.1186/s12879-026-12537.
    PubMed